On-X
Device Cardiology and Vascular Diseases
General payments
$493,913
Research payments
$4,865,536
Through program year 2020, $493,913 in general payments and $4,865,536 in research payments were reported against On-X (Cardiology and Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $252,563 | 367 |
| 2020 | Research | $1,014,820 | 353 |
| 2019 | General | $241,351 | 925 |
| 2019 | Research | $3,850,716 | 251 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
1,292 general · 604 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.